Page 1 of Clinical Trials for ( Astellas Pharma Global Development AND Inc. ) [SPONSOR-COLLABORATORS], 23 Total Matches
- 1CompletedLast Updated: March 27, 2012Condition(s): Pharmacokinetics of ASKP1240; Healthy Volunteers
- 2Active, not recruitingLast Updated: April 19, 2012Condition(s): Pharmacokinetics of ASKP1240; Pharmacodynamics of ASKP1240; Healthy Volunteers
- 3CompletedLast Updated: May 22, 2012Condition(s): Pharmacokinetics of Isavuconazole; Pharmacokinetics of Digoxin; Healthy Volunteers
- 4Not yet recruitingLast Updated: April 18, 2012Condition(s): Candidiasis
- 5RecruitingLast Updated: April 3, 2012Condition(s): Pharmacokinetics of Isavuconazole; Healthy Volunteers
- 6RecruitingLast Updated: April 24, 2012Condition(s): Pharmacokinetics of Isavuconazole; Pharmacokinetics of Methadone; Healthy Volunteers
- 7RecruitingLast Updated: April 24, 2012Condition(s): Psoriasis
- 8Not yet recruitingLast Updated: May 11, 2012Condition(s): Arthritis, Rheumatoid
- 9RecruitingLast Updated: April 3, 2012Condition(s): Pharmacokinetics of Isavuconazole; Healthy Volunteers; Renal Impaired
- 10RecruitingLast Updated: May 1, 2012Condition(s): Leukemia, Myeloid, Acute
- 11RecruitingLast Updated: February 13, 2012Condition(s): Advanced Solid Tumors; Pharmacokinetics of 14C-OSI-906
- 12Active, not recruitingLast Updated: May 11, 2012Condition(s): Pharmacokinetics of Isavuconazole; Pharmacokinetics of Ethinyl Estradiol and Norethindrone; Healthy Volunteers
- 13CompletedLast Updated: March 12, 2012Condition(s): Advanced Pancreatic Cancer
- 14RecruitingLast Updated: June 21, 2011Condition(s): Sickle Cell Disease
- 15RecruitingLast Updated: May 22, 2012Condition(s): Non Small Cell Lung Cancer
- 16Enrolling by invitationLast Updated: February 29, 2012Condition(s): Ependymoma
- 17Active, not recruitingLast Updated: March 9, 2012Condition(s): Non-small Cell Lung Cancer
- 18RecruitingLast Updated: December 22, 2011Condition(s): Myocardial Infarction; Ischemic Heart Disease
- 19RecruitingLast Updated: March 28, 2012Condition(s): Coronary Artery Disease
- 20RecruitingLast Updated: February 29, 2012Condition(s): Recurrent or Refractory Pediatric Ependymoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Astellas+Pharma+Global+Development%2C+Inc.
